Cancer Research
Time-Restricted Eating Shows Promise for Breast Cancer Survivors Over 60
Eight-week study of weekday-only intermittent fasting in older breast cancer survivors with overweight demonstrates feasibility.
Clinical Trial
Mar 28, 2026 0
Results for "Intermittent Hypoxia" in Cancer
20 articles
Cancer Research
Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond
A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.
Clinical Trial
Jun 14, 2026 0
Cancer Research
PULSAR Radiation Plus IMSA101 Immunotherapy Trial in Oligoprogressive Cancers Terminated Early
A Phase 2 trial combining adaptive stereotactic radiotherapy with IMSA101 and checkpoint inhibitors was halted after enrolling only 16 patients.
Clinical Trial
May 14, 2026 0
Cancer Research
High-Intensity Exercise Shows Promise for Men with Early-Stage Prostate Cancer
HIIT training studied in 52 men with prostate cancer on active surveillance to evaluate exercise benefits during watchful waiting.
Clinical Trial
Mar 29, 2026 1
Cancer Research
Physical Therapy and Relaxation Techniques Boost Resilience in Older Lung Cancer Patients
A completed pilot trial tested physical therapy and progressive muscle relaxation to preserve function and mood in older adults with advanced lung cancer.
Clinical Trial
May 12, 2026 0
Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Cancer Research
High-Intensity Exercise During Bladder Cancer Treatment Shows Promise in BRAVE Trial
First study tests whether supervised exercise training is safe and beneficial for bladder cancer patients during treatment.
Clinical Trial
Mar 28, 2026 0
Cancer Research
High-Dose Radiation Therapy Study Reveals Immune System Response Patterns in Cancer
Researchers tracked immune changes during intensive radiation treatment to optimize cancer therapy and potential immunotherapy combinations.
Clinical Trial
Mar 28, 2026 2
Cancer Research
Metronomic Vinorelbine Plus Atezolizumab Tested as Second-Line NSCLC Therapy
A completed Phase 2 trial explores whether low-dose continuous chemotherapy can boost immunotherapy efficacy in advanced lung cancer.
Clinical Trial
Jun 9, 2026 0
Cancer Research
HDAC Inhibitor Plus Checkpoint Blocker Tested in Advanced Lung Cancer Trial
A phase 1/2 trial combined mocetinostat and durvalumab in 83 patients with advanced solid tumors and NSCLC.
Clinical Trial
May 7, 2026 0
Cancer Research
Novel Cancer Treatment Combines Surgery with Direct Immune Therapy Delivery
French researchers test intraperitoneal nivolumab after surgery and heated chemotherapy for advanced ovarian cancer patients.
Clinical Trial
Mar 28, 2026 0
Cancer Research
AI-Guided Cancer Care Program Targets Immunotherapy Gaps in Minority NSCLC Patients
A Columbia University trial tested a digital care service to improve immunotherapy outcomes and reduce healthcare burden for minority lung cancer patients.
Clinical Trial
Jun 15, 2026 0
Cancer Research
Low-Dose Ipilimumab Plus Pembrolizumab Targets Melanoma Brain Metastases
A completed Phase II trial tests whether combining two checkpoint inhibitors can safely and effectively treat melanoma that has spread to the brain.
Clinical Trial
May 7, 2026 0
Cancer Research
Skin Microbiome Shifts Detected in Immunotherapy Rash Patients
A City of Hope study explores whether skin bacteria differ between rash-affected and healthy skin in cancer immunotherapy patients.
Clinical Trial
Jun 6, 2026 0
Cancer Research
16-Week Holistic Program Boosts Quality of Life in Cancer Survivors
A pilot trial tested a comprehensive physical, mental, and spiritual intervention for cancer survivors, tracking outcomes at 6 months post-program.
Clinical Trial
May 28, 2026 0
Cancer Research
Triple Immunotherapy Combo for Recurrent SCLC Terminated After Enrolling 9 Patients
A phase I/II trial combining nivolumab, ipilimumab, and lurbinectedin for relapsed SCLC was terminated early, raising questions about feasibility.
Clinical Trial
May 16, 2026 0
Cancer Research
ISB 1442 Trial for Relapsed Multiple Myeloma Terminated Early
A first-in-human Phase 1/2 trial of ISB 1442 in relapsed/refractory multiple myeloma was halted before completion.
Clinical Trial
Jun 9, 2026 0
Cancer Research
12-Week Exercise Program Targets Body Composition in Breast Cancer Survivors
A completed trial examines how structured exercise reshapes body composition and sustains physical activity habits in breast cancer patients post-diagnosis.
Clinical Trial
Jun 17, 2026 0
Cancer Research
Combo Immunotherapy Plus Liver Embolization Targets Metastatic Uveal Melanoma
A phase II trial tests ipilimumab and nivolumab paired with immunoembolization against liver-spread uveal melanoma.
Clinical Trial
Jun 6, 2026 0
Cancer Research
Phase II Trial Pits Dual Checkpoint Blockade Against Ipilimumab Alone in Advanced Melanoma
NCI-sponsored trial tests whether adding nivolumab to ipilimumab improves outcomes in stage III/IV unresectable melanoma.
Clinical Trial
Jun 16, 2026 0
Page 1 of 2Next